HORIZON-JU-IHI-2023-04-two-stage
HORIZON-JU-IHI-2023-04-two-stage
- Programme
- HORIZON
- Funded projects (dataset)
- 6
- EU contribution (sum)
- €75,354,294
- Portal deadline
- —
Leading topic in historical projects: HORIZON-JU-IHI-2023-04-01-two-stage
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- ARISTOTLE UNIVERSITY OF THESSALONIKI1 coordinated
- LMU MUENCHEN1 coordinated
- SERMAS1 coordinated
- SFU1 coordinated
- UPM1 coordinated
- UGent1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- ROCHE3 topic projects
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED3 topic projects
- NOVARTIS3 topic projects
- AU2 topic projects
- ABBVIE INC2 topic projects
- ASTRAZENECA AB2 topic projects
- BAYER AKTIENGESELLSCHAFT2 topic projects
- BII GMBH2 topic projects
- BREAKTHROUGH T1D2 topic projects
- ELI LILLY AND COMPANY2 topic projects
- Eli Lilly Kinsale Ltd2 topic projects
- FSJD-CERCA2 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- Novo Nordisk · BII GMBH5 shared
DK ↔ DE
- Novo Nordisk · SARD4 shared
DK ↔ FR
- Novo Nordisk · Sanofi US Services Inc.4 shared
DK ↔ US
- PFIZER · PFIZER INC4 shared
UK ↔ US
- BII GMBH · BI PHARMA GMBH4 shared
DE ↔ DE
- 4 shared
- SARD · Sanofi US Services Inc.4 shared
FR ↔ US
- Novo Nordisk · BI PHARMA GMBH4 shared
DK ↔ DE
- 4 shared
- Sanofi US Services Inc. · BII GMBH4 shared
US ↔ DE
- PFIZER · Pfizer R&D UK Limited4 shared
UK ↔ UK
- PFIZER INC · Pfizer R&D UK Limited4 shared
US ↔ UK
- JANSSEN PHARMACEUTICA NV · FSJD-CERCA3 shared
BE ↔ ES
- Lilly Deutschland GmbH · PFIZER INC3 shared
DE ↔ US
- JANSSEN PHARMACEUTICA NV · ABBVIE INC3 shared
BE ↔ US
- 3 shared
- Lilly Deutschland GmbH · PFIZER3 shared
DE ↔ UK
- JANSSEN PHARMACEUTICA NV · IRIS3 shared
BE ↔ FR
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 54.33
- Median orgs / project
- 53
- Min / max orgs
- 32 – 80
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- Germany44
- United Kingdom36
- Spain34
- Belgium32
- France31
- United States30
- Italy20
- Netherlands18
- Switzerland16
- Denmark14
- Sweden10
- Greece7
- Austria7
- Ireland6
- Poland3
- Czechia2
- Luxembourg2
- Lithuania2
Organization types
- company93 orgs · 161 rows
- university42 orgs · 46 rows
- research_institute38 orgs · 43 rows
- sme41 orgs · 41 rows
- other24 orgs · 25 rows
- public_body9 orgs · 10 rows
Topics in funded projects
- HORIZON-JU-IHI-2023-04-01-two-stageHORIZON-JU-IHI-2023-04-01-two-stage· 1 projects
- HORIZON-JU-IHI-2023-04-02-two-stageHORIZON-JU-IHI-2023-04-02-two-stage· 1 projects
- HORIZON-JU-IHI-2023-04-03-two-stageHORIZON-JU-IHI-2023-04-03-two-stage· 1 projects
- HORIZON-JU-IHI-2023-04-04-two-stageHORIZON-JU-IHI-2023-04-04-two-stage· 1 projects
- HORIZON-JU-IHI-2023-04-05-two-stageHORIZON-JU-IHI-2023-04-05-two-stage· 1 projects
- HORIZON-JU-IHI-2023-04-06-two-stageHORIZON-JU-IHI-2023-04-06-two-stage· 1 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| READI Research in Europe and Diversity Inclusion | HORIZON | €31,538,000 |
| PharmEco Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing | HORIZON | €16,035,533 |
| RealiseD Comprehensive methodological and operational approach to clinical trials in rare and ultra-rare diseases | HORIZON | €8,500,000 |
| NHPig Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models | HORIZON | €8,499,556 |
| ENKORE Propelling the shift toward the future of circular, safe and sustainable packaging and single use device ecoDesigned solutions through healthcare environments | HORIZON | €7,742,500 |
| Project-COMFORT Patient-Centric blOod saMpling FOr impRoved healThcare (Project-COMFORT) | HORIZON | €3,038,705 |